Pharmacotherapy for anxiety disorders in children and adolescents
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
Anxiety disorders are the most common mental health diagnoses in youth, and carry risks for ongoing impairments and subsequent development of other psychiatric comorbidities into adulthood. This article discusses considerations for assessment and treatment of anxiety disorders in youth, with a focus on the evidence base of pharmacologic treatment and important clinical considerations to optimize care. We then briefly describe the impact of anxiety on neuronal elements of fear circuitry to highlight how treatments may ameliorate impairments through enhanced plasticity Overall, pharmacotherapy for anxiety disorders is effective in improving clinical symptoms, particularly in combination with psychotherapy. Response is typically seen within several weeks, yet longitudinal studies are limited. Selective serotonin reuptake inhibitors are thought to be relatively safe and effective for acute treatment of several classes of anxiety disorders in youth, with increasing evidence supporting the role of neuronal plasticity in recovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“On the contrary, benzodiazepines and tricyclic antidepressants were not effective at promoting a decrease in anxiety symptoms.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, research on these medications for this population is limited, and their use is generally not preferred over SSRIs and SNRIs and should only be used with great caution and close monitoring in this population because of the adverse side effect profile [31,34,35].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, meta-analyses and reviews have demonstrated that CBT is more effective in treating SAD compared to waitlist controls, treatment as usual and placebo conditions [32,35].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In sum, our review of the literature suggests that despite the efficacy of SSRIs for pediatric SAD, psychotherapy alone or in combination with pharmacological treatment is the preferred treatment approach because it poses less risk of causing adverse effects and dropout [35,45].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When sertraline and CBT are combined as a treatment, it is more effective than any other monotherapeutic treatment modality alone at decreasing anxiety symptoms and improving response rates.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [35]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318179964f · Cited by 3,399
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
Shin, L. M., & Liberzon, I. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.83 · Cited by 2,083
ADULT NEUROGENESIS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM
Ming, G.-L., & Song, H. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.051804.101459 · Cited by 1,839
Enriched environments, experience-dependent plasticity and disorders of the nervous system
Nithianantharajah, J., & Hannan, A. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1970 · Cited by 1,771
Stress, memory and the amygdala
Roozendaal, B., McEwen, B. S., & Chattarji, S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2651 · Cited by 1,760
Vyas, A., Mitra, R., Shankaranarayana Rao, B. S., & Chattarji, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06810.2002 · Cited by 1,662
Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., Ginsburg, G. S., Rynn, M. A., McCracken, J., Waslick, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804633 · Cited by 1,442
Treating anxiety disorders in children: Results of a randomized clinical trial.
Kendall, P. C. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.62.1.100 · Cited by 1,376
Recovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227
Black, J. E., Isaacs, K. R., Anderson, B. J., Alcantara, A. A., & Greenough, W. T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5568 · Cited by 1,161
A family study of obsessive–compulsive disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.76 · Cited by 1,022
Therapy for youths with anxiety disorders: A second randomized clincal trial.
Kendall, P. C., Flannery-Schroeder, E., Panichelli-Mindel, S. M., Southam-Gerow, M., Henin, A., & Warman, M. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.3.366 · Cited by 984
Liston, C., Miller, M. M., Goldwater, D. S., Radley, J. J., Rocher, A. B., Hof, P. R., Morrison, J. H., & McEwen, B. S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1184-06.2006 · Cited by 968
Plasticity of the Hippocampus: Adaptation to Chronic Stress and Allostatic Load
McEwen, B. S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05830.x · Cited by 873
Sousa, N., Lukoyanov, N. V., Madeira, M. D., Almeida, O. F. X., & Paula-Barbosa, M. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00050-6 · Cited by 758
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667
Champagne, D. L., Bagot, R. C., van Hasselt, F., Ramakers, G., Meaney, M. J., de Kloet, E. R., Joels, M., & Krugers, H. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0526-08.2008 · Cited by 661
Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441703 · Cited by 588
Internalizing Disorders in Childhood
Kovacs, M., & Devlin, B. (1998) · Journal of Child Psychology and Psychiatry · doi:10.1017/s0021963097001765 · Cited by 567
Connolly, S. D., & Bernstein, G. A. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246070.23695.06 · Cited by 548
Cohen, J. A. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2009.12.020 · Cited by 520 · cited 1×
“Some studies have shown benefit from SSRIs,(47) yet trauma-focused CBT has shown more consistent effectiveness.(47) To date, no RCTs have examined medication effects in children or adolescents with panic disorder.”
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.012 · Cited by 510 · cited 1×
“While D-cycloserine does not have direct benefits in the absence of other treatments, it is thought to increase the efficacy of psychotherapy by facilitating mechanisms of neuroplasticity.(75) Complementary and alternative remedies are often tried by families prior to seeking psychiatric treatment.”
King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482
Pediatric Symptom Checklist: Screening school-age children for psychosocial dysfunction
Jellinek, M. S., Murphy, J. M., Robinson, J., Feins, A., Lamb, S., & Fenton, T. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80056-8 · Cited by 472
March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., Cutler, N. R., Dominguez, R., Ferguson, J., Muller, B., et al. (1998) · JAMA · doi:10.1001/jama.280.20.1752 · Cited by 469
Ernst, E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-1-200201010-00010 · Cited by 461
Treating Sexually Abused Children With Posttraumatic Stress Symptoms: A Randomized Clinical Trial
KING, N. J., TONGE, B. J., MULLEN, P., MYERSON, N., HEYNE, D., ROLLINGS, S., MARTIN, R., & OLLENDICK, T. H. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200011000-00008 · Cited by 444
Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives.
Longo, L. P., & Johnson, B. (2000) · PubMed · Cited by 420
Cognitive-Behavioral Family Treatment of Childhood Obsessive-Compulsive Disorder: A Controlled Trial
Barrett, P., Healy-Farrell, L., & March, J. S. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200401000-00014 · Cited by 417
Woon, F. L., & Hedges, D. W. (2008) · Hippocampus · doi:10.1002/hipo.20437 · Cited by 416
RIDDLE, M. A., REEVE, E. A., YARYURA-TOBIAS, J. A., YANG, H. M., CLAGHORN, J. L., GAFFNEY, G., GREIST, J. H., HOLLAND, D., MCCONVILLE, B. J., PIGOTT, T., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00017 · Cited by 402
Evaluation of cognitive-behavioral group treatments for childhood anxiety disorders
Barrett, P. M. (1998) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2704_10 · Cited by 399
Fluoxetine for the Treatment of Childhood Anxiety Disorders
BIRMAHER, B., AXELSON, D. A., MONK, K., KALAS, C., CLARK, D. B., EHMANN, M., BRIDGE, J., HEO, J., & BRENT, D. A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000037049.04952.9f · Cited by 385
Family-Based Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
STORCH, E. A., GEFFKEN, G. R., MERLO, L. J., MANN, G., DUKE, D., MUNSON, M., ADKINS, J., GRABILL, K. M., MURPHY, T. K., & GOODMAN, W. K. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31803062e7 · Cited by 382
Volkmar, F., Cook, E. H., Pomeroy, J., Realmuto, G., & Tanguay, P. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/s0890-8567(99)80003-3 · Cited by 382
Oomen, C. A., Soeters, H., Audureau, N., Vermunt, L., van Hasselt, F. N., Manders, E. M. M., Joëls, M., Lucassen, P. J., & Krugers, H. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0247-10.2010 · Cited by 361
RIDDLE, M. A., SCAHILL, L., KING, R. A., HARDIN, M. T., ANDERSON, G. M., ORT, S. I., SMITH, J. C., LECKMAN, J. F., & COHEN, D. J. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199211000-00011 · Cited by 345
Goldwater, D. S., Pavlides, C., Hunter, R. G., Bloss, E. B., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.053 · Cited by 333
Guastella, A. J., Richardson, R., Lovibond, P. F., Rapee, R. M., Gaston, J. E., Mitchell, P., & Dadds, M. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.011 · Cited by 326 · cited 1×
“Two RCTs have supported its use as an augmentation strategy for youth with OCD(73) and social anxiety disorder.(74) While D-cycloserine does not have direct benefits in the absence of other treatments, it is thought to increase the efficacy of psychotherapy by facilitating mechanisms of neuroplasticity.”
Rynn, M. A., Siqueland, L., & Rickels, K. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2008 · Cited by 321
Family Cognitive Behavioral Therapy for Child Anxiety Disorders
WOOD, J. J., PIACENTINI, J. C., SOUTHAM-GEROW, M., CHU, B. C., & SIGMAN, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000196425.88341.b0 · Cited by 316
Differences between mentally retarded and normally intelligent autistic children
Bartak, L., & Rutter, M. (1976) · Journal of Autism and Childhood Schizophrenia · doi:10.1007/bf01538054 · Cited by 314
Neuronal plasticity: A link between stress and mood disorders
Calabrese, F., Molteni, R., Racagni, G., & Riva, M. A. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.014 · Cited by 301
COHEN, J. A., MANNARINO, A. P., PEREL, J. M., & STARON, V. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180547105 · Cited by 300 · cited 3×
“This method is also thought to apply to pediatric depression(38) and complex forms of ADHD,(39) while evidence for combination therapy is limited for youth with PTSD.(40,41) Other agents with demonstrated efficacy for youth with non-OCD anxiety include fluvoxamine(42,43) and fluoxetine.”
Propranolol Treatment for Childhood Posttraumatic Stress Disorder, Acute Type: A Pilot Study
Famularo, R. (1988) · American Journal of Diseases of Children · doi:10.1001/archpedi.1988.02150110122036 · Cited by 296
MANASSIS, K., MENDLOWITZ, S. L., SCAPILLATO, D., AVERY, D., FIKSENBAUM, L., FREIRE, M., MONGA, S., & OWENS, M. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200212000-00013 · Cited by 282
Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder
Pande, A. C., Pollack, M. H., Crockatt, J., Greiner, M., Chouinard, G., Lydiard, R. B., Taylor, C. B., Dager, S. R., & Shiovitz, T. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00011 · Cited by 279
Treatment of Elective Mutism with Fluoxetine: A Double-Blind, Placebo-Controlled Study
BLACK, B., & UHDE, T. W. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199409000-00010 · Cited by 278
Fawcett, J., & Barkin, R. L. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0306 · Cited by 266
A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1566 · Cited by 248
Wagner, K. D., Berard, R., Stein, M. B., Wetherhold, E., Carpenter, D. J., Perera, P., Gee, M., Davy, K., & Machin, A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1153 · Cited by 240 · cited 2×
“Another RCT examining sertraline for youth with OCD also found significantly greater improvement after active treatment compared with placebo,(24) with lasting effects in 70% of patients who were examined 12 months later.(35) A 10-week RCT of pediatric outpatients with OCD showed fluvoxamine to be effective.”
GELLER, D. A., WAGNER, K. D., EMSLIE, G., MURPHY, T., CARPENTER, D. J., WETHERHOLD, E., PERERA, P., MACHIN, A., & GARDINER, C. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000138356.29099.f1 · Cited by 234
Southam-Gerow, M. A., Kendall, P. C., & Weersing, V. R. (2001) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3003_13 · Cited by 227
Implications of adult hippocampal neurogenesis in antidepressant action
Malberg, J. E. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0422 · Cited by 217
Imipramine Plus Cognitive-Behavioral Therapy in the Treatment of School Refusal
BERNSTEIN, G. A., BORCHARDT, C. M., PERWIEN, A. R., CROSBY, R. D., KUSHNER, M. G., THURAS, P. D., & LAST, C. G. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200003000-00008 · Cited by 216
Reversal of hippocampal neuronal maturation by serotonergic antidepressants
Kobayashi, K., Ikeda, Y., Sakai, A., Yamasaki, N., Haneda, E., Miyakawa, T., & Suzuki, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912690107 · Cited by 212
Clonidine for Posttraumatic Stress Disorder in Preschool Children
HARMON, R. J., & RIGGS, P. D. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199609000-00022 · Cited by 205
Imipramine Treatment of Children with Separation Anxiety Disorder
KLEIN, R. G., KOPLEWICZ, H. S., & KANNER, A. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00005 · Cited by 201
School Phobia: A Therapeutic Trial with Clomipramine and Short-Term Outcome
Berney, T., Kolvin, I., Bhate, S. R., Garside, R. F., Jeans, J., Kay, B., & Scarth, L. (1981) · British Journal of Psychiatry · doi:10.1192/bjp.138.2.110 · Cited by 198
Storch, E. A., Murphy, T. K., Goodman, W. K., Geffken, G. R., Lewin, A. B., Henin, A., Micco, J. A., Sprich, S., Wilhelm, S., Bengtson, M., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.015 · Cited by 193
Fluoxetine in Children and Adolescents With OCD: A Placebo-Controlled Trial
LIEBOWITZ, M. R., TURNER, S. M., PIACENTINI, J., BEIDEL, D. C., CLARVIT, S. R., DAVIES, S. O., GRAAE, F., JAFFER, M., LIN, S.-H., SALLEE, F. R., et al. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200212000-00014 · Cited by 188
Rynn, M. A., Riddle, M. A., Yeung, P. P., & Kunz, N. R. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.290 · Cited by 188
Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Farrell, C., Wagner, K. D., Emslie, G., & Carpenter, D. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322126313 · Cited by 187
Comparative Studies of Pharmacotherapy for School Refusal
BERNSTEIN, G. A., GARFINKEL, B. D., & BORCHARDT, C. M. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199009000-00016 · Cited by 186
Aisa, B., Elizalde, N., Tordera, R., Lasheras, B., Del Río, J., & Ramírez, M. J. (2009) · Hippocampus · doi:10.1002/hipo.20586 · Cited by 178
SIMEON, J. G., FERGUSON, H. B., KNOTT, V., ROBERTS, N., GAUTHIER, B., DUBOIS, C., & WIGGINS, D. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00006 · Cited by 177
Clonazepam in Childhood Anxiety Disorders
GRAAE, F., MILNER, J., RIZZOTTO, L., & KLEIN, R. G. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199403000-00011 · Cited by 176
Selective Serotonin Reuptake Inhibitors in Autism: A Review of Efficacy and Tolerability
Kolevzon, A., Mathewson, K. A., & Hollander, E. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0311 · Cited by 176
Psychiatric Comorbidities among Female Adolescents with Anorexia Nervosa
Salbach‐Andrae, H., Lenz, K., Simmendinger, N., Klinkowski, N., Lehmkuhl, U., & Pfeiffer, E. F. (2007) · Child Psychiatry & Human Development · doi:10.1007/s10578-007-0086-1 · Cited by 172
Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders
Grayson, D. R., Kundakovic, M., & Sharma, R. P. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061333 · Cited by 171
Pharmacotherapy for anxiety disorders in children and adolescents
Ipser, J. C., Stein, D. J., Hawkridge, S., & Hoppe, L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005170.pub2 · Cited by 159
A Randomized Controlled Trial of Venlafaxine ER Versus Placebo in Pediatric Social Anxiety Disorder
March, J. S., Entusah, A. R., Rynn, M., Albano, A. M., & Tourian, K. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.025 · Cited by 156 · cited 1×
“Another 16-week RCT of venlafaxine XR in children with social anxiety showed significant benefit beyond placebo.(49) However, studies of venlafaxine in children indicated a risk for elevated blood pressure, decreased growth rate, and increased suicidal ideation, which should be considered with families prior to initia…”
Branchi, I. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.011 · Cited by 156
Bentz, D., Michael, T., de Quervain, D. J. ‐., & Wilhelm, F. H. (2009) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2009.10.011 · Cited by 151
Abikoff, H., McGough, J. J., Vitiello, B., McCracken, J. T., Davies, M., Walkup, J. T., Riddle, M. A., Oatis, M. D., Greenhill, L. L., Skrobala, A. M., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000155320.52322.37 · Cited by 149
Evidence-Based Treatments in Child and Adolescent Psychiatry: An Inventory
McClellan, J., & WERRY, J. S. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200312000-00005 · Cited by 149
Eiland, L., & McEwen, B. S. (2012) · Hippocampus · doi:10.1002/hipo.20862 · Cited by 147
Molteni, R., Calabrese, F., Cattaneo, A., Mancini, M., Gennarelli, M., Racagni, G., & Riva, M. A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.208 · Cited by 142
Stein, D. J., Ipser, J., & McAnda, N. (2009) · PubMed · Cited by 140
Faustino, T. T., de Almeida, R. B., & Andreatini, R. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010005000026 · Cited by 140
Emotion regulation and binge eating in children
Czaja, J., Rief, W., & Hilbert, A. (2009) · International Journal of Eating Disorders · doi:10.1002/eat.20630 · Cited by 139
The phenomenology of hairpulling in a community sample
Duke, D. C., Bodzin, D. K., Tavares, P. D. S. P. B., Geffken, G. R., & Storch, E. A. (2009) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2009.07.015 · Cited by 139
Robb, A. S., Cueva, J. E., Sporn, J., Yang, R., & Vanderburg, D. G. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0115 · Cited by 132
Anxiety Disorders in Children and Adolescents
Rockhill, C., Kodish, I., DiBattisto, C., Macias, M., Varley, C., & Ryan, S. (2010) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2010.02.002 · Cited by 110
Self-citationOpen questions in current models of antidepressant action
Tanti, A., & Belzung, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00585.x · Cited by 109
Tolin, D. F., Franklin, M. E., Diefenbach, G. J., Anderson, E., & Meunier, S. A. (2007) · Cognitive Behaviour Therapy · doi:10.1080/16506070701223230 · Cited by 108
(2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386879 · Cited by 89
THOMSEN, P. H. (1997) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1997.7.157 · Cited by 89
FIGUEROA, Y., ROSENBERG, D. R., BIRMAHER, B., & KESHAVAN, M. S. (1998) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1998.8.61 · Cited by 84
Psychopathology in adolescent alcohol abuse and dependence.
Clark, D. B., & Bukstein, O. G. (1998) · Europe PMC (PubMed Central) · Cited by 82
Reinblatt, S. P., dosReis, S., Walkup, J. T., & Riddle, M. A. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.040 · Cited by 81
Xu, H., Luo, C., Richardson, J. S., & Li, X.-M. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500265 · Cited by 81
A Hypothesized Role for Dendritic Remodeling in the Etiology of Mood and Anxiety Disorders
Gorman, J. M., & Docherty, J. P. (2010) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2010.22.3.256 · Cited by 79
Krystal, J. H., Tolin, D. F., Sanacora, G., Castner, S. A., Williams, G. V., Aikins, D. E., Hoffman, R. E., & D'Souza, D. C. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.05.002 · Cited by 76 · cited 1×
“Selective serotonin uptake inhibitors (SSRIs) and other treatment modalities are thought to facilitate these neurochemical and neuroanatomical enhancements, contributing to clinical effectiveness.(2) This enhanced neuroplasticity may also contribute to better response rates by augmenting other interventions such as ps…”
Pine, D. S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386888 · Cited by 73
Nothing to fear? Neural systems supporting avoidance behavior in healthy youths
Schlund, M. W., Siegle, G. J., Ladouceur, C. D., Silk, J. S., Cataldo, M. F., Forbes, E. E., Dahl, R. E., & Ryan, N. D. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.244 · Cited by 69
Depression, anxiety, and functional impairment in children with trichotillomania
Lewin, A. B., Piacentini, J., Flessner, C. A., Woods, D. W., Franklin, M. E., Keuthen, N. J., Moore, P., Khanna, M., March, J. S., Stein, D. J., et al. (2008) · Depression and Anxiety · doi:10.1002/da.20537 · Cited by 68 · cited 1×
“Although trichotillomania, or impulsive repetitive hairpulling, is listed as an impulse control disorder, the triggers for repetitive hair-pulling are often anxious thoughts,(95) and urges to pull are typically accompanied by anxiety.(95,96) However, treatment studies using SSRIs have shown low response rates.”
Pharmacotherapy for Eating Disorders and Obesity
Powers, P. S., & Bruty, H. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2008.07.009 · Cited by 63
Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania
Stein, D. J., Bouwer, C., & Maud, C. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900220 · Cited by 58
Alaghband‐Rad, J., & Shooshtari, M. H. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-007-0634-z · Cited by 55
Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia
Mrakotsky, C., Masek, B. J., Biederman, J., Raches, D., Hsin, O., Forbes, P., de Moor, C., DeMaso, D. R., & Gonzalez–Heydrich, J. (2007) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2007.01.005 · Cited by 52
Anxiolytics for Children and Adolescents: Traditional and New Drugs
Coffey, B. J. (1990) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1990.1.57 · Cited by 49
Outcomes for treated anxious children: a critical review of Long-Term-Follow-Up studies
Nevo, G. A., & Manassis, K. (2009) · Depression and Anxiety · doi:10.1002/da.20584 · Cited by 47
The use of clonidine in post-traumatic stress disorder.
Porter, D. M., & Bell, C. (1999) · PubMed · Cited by 46
Functional Magnetic Resonance Imaging and Pediatric Anxiety
Gerber, A. J., Peterson, B. S., Pine, D. S., Guyer, A. E., & Leibenluft, E. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318185dad0 · Cited by 36
Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning.
Singh, T., Prakash, A., Rais, T., & Kumari, N. (2009) · PubMed Central · Cited by 33
Psychopharmacology and Preschoolers: A Critical Review of Current Conditions
Fanton, J. H., & Gleason, M. M. (2009) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2009.02.005 · Cited by 32
Mukaddes, N. M., Abali, O., & Kaynak, N. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01139.x · Cited by 32
Schirman, S., Kronenberg, S., Apter, A. S., Brent, D. A., Melhem, N., Pick, N., Carmel, M., Frisch, A., Weizman, A., & Gothelf, D. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0330-x · Cited by 30
Safer, D. J. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0215 · Cited by 26
School phobia: controlled imipramine treatment.
Gittelman-Klein, R., & Klein, D. F. (1971) · PubMed · Cited by 24
A controlled trial of clomipramine in childhood obsessive compulsive disorder.
Flament, M. F., Jl, R., & Kilts, C. D. (1985) · PubMed · Cited by 24
Recent Trends and a Developmental Approach to Substance Abuse in Adolescents
Chatlos, J. C. (1996) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30382-1 · Cited by 22
Gabapentin and Tiagabine for Social Anxiety
Urbano, M. R., Spiegel, D. R., Laguerta, N., Shrader, C. J., Rowe, D. F., & Hategan, L. F. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08l00641 · Cited by 10
Research works printed but not linked: 8
- Irwin C. The adolescent visit. In: Rudolph C, Rudolph A, Hostetter M, Lister G, Siegel N, eds. Rudolph's Pediatrics. 21st ed. New York, NY: McGraw Hill; 2002 234 238
- Chiang O. Anxiety disorders. In: Garfunkel L, Kaczorowski J, Christy C, eds. Mosby's Pediatric Clinical Advisor: Instant Diagnosis and Treatment. 2nd ed. St. Louis, MO: Mosby, Inc; 2007
- Varley C. Varley J. Smith C. Anxiety disorders in children and adolescents. In: Greydanus D, Patel D, Pratt H, eds. Behavioral Pediatrics. 2nd ed. New York, NY: iUniverse, Inc;. 2006 618 650
- Kendall P. Hedtke K. Cognitive-Behavioral Therapy for Anxious Children: Therapist Manual. 3rd ed. Ardmore, PA: Workbook Publishing; 2006
- Perry B. Szalavitz M. The Boy Who Was Raised as a Dog and Other Stories from a Child Psychiarist's Notebook - What Traumatized Children Can Teach Us About Loss, Love, and Healing. New York, NY: Basic Books; 2008
- Anderson J. Epidemiological Issues. In: OllendickT, King N, Yule W, eds. International Handbook of Phobia and Anxiety disorders in Children and Adolescents. New York: Plenum Press; 1994
- Kendall P. Hedtke K. Aschenbrand S. Behavioral and emotional disorders in adolescents. Nature, assessment and treatment. In: Wolfe DA, Mash EJ, eds. Anxiety Disorders. New York, NY: Guilford Press; 2006 259 299
- Field B. Two drugs test ineffective in treating autism. Autism Examiner. 2009
Cited by
Behavioural and emotional disorders in childhood: A brief overview for paediatricians
Ogundele, M. O. (2018) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v7.i1.9 · Cited by 471
Wolff, A., Joshi, R. K., Ekström, J., Aframian, D., Pedersen, A. M. L., Proctor, G., Narayana, N., Villa, A., Sia, Y. W., Aliko, A., et al. (2017) · Drugs in R&D · doi:10.1007/s40268-016-0153-9 · Cited by 364
Cohen Kadosh, K., Muhardi, L., Parikh, P., Basso, M., Jan Mohamed, H. J., Prawitasari, T., Samuel, F., Ma, G., & Geurts, J. M. W. (2021) · Nutrients · doi:10.3390/nu13010199 · Cited by 159
Hippocampal HDAC4 Contributes to Postnatal Fluoxetine-Evoked Depression-Like Behavior
Sarkar, A., Chachra, P., Kennedy, P., Pena, C. J., Desouza, L. A., Nestler, E. J., & Vaidya, V. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.73 · Cited by 79
Askari, S., & Salpekar, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00080-9 · Cited by 74
Metadata
- Authors
- Kodish, I., Rockhill, C., & Varley, C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Kodish, Ian
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2011-12-31
- Volume
- 13
- Issue
- 4
- Pages
- 439-452
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- PMC
- PMC3263391
- OpenAlex
- W2952704118
- Cited by
- 62
- References
- 120
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 1 · 2012: 2
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- anxiety disorders, children and adolescents, pharmacotherapy, selective serotonin reuptake inhibitors, fear circuitry, neuroplasticity, psychotherapy, psychiatric comorbidity, treatment response
- MeSH terms
- Adolescent, Anxiety Disorders, Child, Humans, Neuronal Plasticity, Anti-Anxiety Agents, Selective Serotonin Reuptake Inhibitors, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.